Vinorelbine and intermittent cyclophosphamide sensitize an aggressive myc-driven b-cell lymphoma to anti-pd-1 by an immunological memory effective against tumor re-challenge

HIGHLIGHTS

• who: Stefania Orecchioni and collaborators from the Laboratory of Hematology-Oncology, European Institute of Oncology IRCCS, Via Ripamonti, Milan, Italy have published the Article: Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge, in the Journal: (JOURNAL)
• what: In the present manuscript the authors report the generation of a highly aggressive anti-PD-1 resistant model of a high-grade Myc-driven B-cell non-Hodgkin`s lymphoma (NHL) that can be controlled in vivo by TT but not . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.